Skip Navigation

Cardiovascular Research 2000 47(4):788-796; doi:10.1016/S0008-6363(00)00139-5
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ausma, J.
Right arrow Articles by Borgers, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ausma, J.
Right arrow Articles by Borgers, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation

Jannie Ausmaa,b,*, Will A Coumansa, Hans Duimelb, Ger J Van der Vussea, Maurits A Allessiea and Marcel Borgersb

aDepartment of Physiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands
bDepartment of Molecular Cell Biology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands

* Corresponding author. Tel.: +31-43-388-1076; fax: +31-43-388-4166 jannie.ausma{at}fys.unimaas.nl

Objective: Prolonged atrial fibrillation (AF) results in (ultra)structural remodelling of atrial cardiomyocytes resembling alterations seen in ischemia-induced ventricular hibernation. The mechanisms underlying these changes are incompletely understood. In the present study we explored the hypothesis that a profound imbalance in energy status during chronic AF acts as a stimulus for structural remodelling. Methods and Results: The content of high energy-phosphates and related compounds together with a selected number of mitochondrial enzymes, known to be altered under ischemic conditions, were determined in tissue samples taken from atria of goats in sinus rhythm (SR) and after 1, 2, 4, 8 and 16 weeks of AF maintained by burst pacing. Atrial remodelling was quantified by counting the percentage of cells with >10% myolysis. During AF structural remodelling developed progressively, after 8 weeks about 40% of the atrial myocytes were affected. The concentration of adenine nucleotides and their degradation products did not change significantly during AF. Also the activity of mitochondrial cytochrome c oxidase activity was similar during AF and SR. Mitochondrial NADH-oxidase and proton-translocating ATPase activities were not induced by AF. The tissue content of phosphocreatine decreased during the first week by 60%, but completely recovered between 8 and 16 weeks of AF. Conclusions: The analysis of adenine nucleotides during AF provided no indication for the development of severe atrial ischemia. This notion is supported by enzyme cytochemical findings. However, AF-induced atrial remodelling was associated with a transient lowering of phosphocreatine content, suggesting an increase in energy demand during the early phase of AF. The subsequent recovery of the phosphocreatine pool indicates restoration of the balance between energy demand and supply in chronically fibrillating atria.

KEYWORDS Atrial function; Energy metabolism; Hibernation; Mitochondria; Remodeling; Supraventr. arrhythmia


{star} This study was presented in part at the 72nd Annual Scientific Session of the American Heart Association (Circulation 1999;100:I-11).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
L. Pretorius, X.-J. Du, E. A. Woodcock, H. Kiriazis, R. C.Y. Lin, S. Marasco, R. L. Medcalf, Z. Ming, G. A. Head, J. W. Tan, et al.
Reduced Phosphoinositide 3-Kinase (p110{alpha}) Activation Increases the Susceptibility to Atrial Fibrillation
Am. J. Pathol., September 1, 2009; 175(3): 998 - 1009.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
A. S. Barth and G. F. Tomaselli
Cardiac Metabolism and Arrhythmias
Circ Arrhythm Electrophysiol, June 1, 2009; 2(3): 327 - 335.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Mayr, S. Yusuf, G. Weir, Y.-L. Chung, U. Mayr, X. Yin, C. Ladroue, B. Madhu, N. Roberts, A. De Souza, et al.
Combined metabolomic and proteomic analysis of human atrial fibrillation.
J. Am. Coll. Cardiol., February 5, 2008; 51(5): 585 - 594.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Casaclang-Verzosa, B. J. Gersh, and T. S.M. Tsang
Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
J. Am. Coll. Cardiol., January 1, 2008; 51(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Voigt, A. Friedrich, M. Bock, E. Wettwer, T. Christ, M. Knaut, R. H. Strasser, U. Ravens, and D. Dobrev
Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation
Cardiovasc Res, June 1, 2007; 74(3): 426 - 437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-M. Cha, P. P. Dzeja, M. M. Redfield, W. K. Shen, and A. Terzic
Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilat
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1686 - H1692.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. S. Barth, S. Merk, E. Arnoldi, L. Zwermann, P. Kloos, M. Gebauer, K. Steinmeyer, M. Bleich, S. Kaab, M. Hinterseer, et al.
Reprogramming of the Human Atrial Transcriptome in Permanent Atrial Fibrillation: Expression of a Ventricular-Like Genomic Signature
Circ. Res., May 13, 2005; 96(9): 1022 - 1029.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. Wasson, H. K. Reddy, and M. L. Dohrmann
Current Perspectives of Electrical Remodeling and Its Therapeutic Implications
Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2004; 9(2): 129 - 144.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-M. Cha, P. P. Dzeja, W. K. Shen, A. Jahangir, C. Y. T. Hart, A. Terzic, and M. M. Redfield
Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability
Am J Physiol Heart Circ Physiol, April 1, 2003; 284 (4): H1313 - H1320.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Shinagawa, H. Mitamura, S. Ogawa, and S. Nattel
Effects of inhibiting Na+/H+-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling
Cardiovasc Res, May 1, 2002; 54(2): 438 - 446.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. L.J.L. Thijssen, J. Ausma, and M. Borgers
Structural remodelling during chronic atrial fibrillation: act of programmed cell survival
Cardiovasc Res, October 1, 2001; 52(1): 14 - 24.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.